Agentix (FWDR) Return on Equity ROE from the second quarter 2026 to second quarter 2026 and annually, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Agentix Corp   (FWDR)

Agentix 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Agentix in the second quarter 2026?
Due to the lack of equity, it was not possible to calculate Agentix Corp 's return on equity (ROE) in its second quarter 2026

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2026)
II. Quarter		 (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 0 0 0 -1 -1
Return On Equity (TTM) - - - - -
FWDR's Total Ranking # # # # #
Equity (TTM) in Millions -4 -4 -4 -3 -3
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to FWDR Management Effectiveness >> FWDR's 5 Years Annual ROE >> Compare FWDR ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





FWDR Annual Return On Equity (Mar 31 2026)
2026		 (Mar 31 2025)
2025		 (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2022)
2022
Total Equity in Millions -4 -3 -3 -2 -1
Y / Y Equity Change - - - - -
Net Income in Millions 0 -1 -1 -1 -3
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to FWDR Management Effectiveness >> FWDR's 5 Years Annual ROE >> Compare FWDR ROE to its Competitors




More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
FWDR's' Return on Equity at Yahoo Finance
FWDR's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for FWDR's Competitors
Subscribers only: Roe for Agentix 's Suppliers
Subscribers only: Return On Equity for FWDR's Customers




Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector ROE
Pro dex Inc   26.91 %
Sotera Health Company  26.41 %
Pacs Group Inc   25.65 %
Standard Biotools Inc   25.58 %
Resmed Inc   25.50 %
Bioventus Inc   24.60 %
Encompass Health Corporation  24.08 %
Iradimed Corporation  23.90 %
Corcept Therapeutics Inc  22.88 %
Msa Safety Inc  21.79 %
Lantheus Holdings Inc   21.72 %
Iqvia Holdings Inc   21.40 %
Denali Therapeutics Inc   21.40 %
West Pharmaceutical Services Inc   21.08 %
Brightspring Health Services Inc   20.31 %
Healthcare Services Group Inc   20.22 %
Vertex Pharmaceuticals Inc  20.08 %
Ge Healthcare Technologies Inc   20.04 %
Neurocrine Biosciences Inc   19.74 %
Ani Pharmaceuticals Inc  19.70 %
Johnson and Johnson  19.55 %
Pediatrix Medical Group Inc   17.28 %
Kiniksa Pharmaceuticals International Plc  17.27 %
Krystal Biotech Inc   17.02 %
Intuitive Surgical Inc   16.99 %
Ensign Group Inc  16.62 %
Lemaitre Vascular Inc   15.81 %
Stryker Corp  15.61 %
Quest Diagnostics Inc  15.22 %
Regeneron Pharmaceuticals Inc   15.07 %

Date modified: 2026-11-07T06:45:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.